AR109456A2 - Uso de et743 para la preparación de un medicamento para el tratamiento de un paciente humano afectado por cáncer mediante terapia de combinación - Google Patents
Uso de et743 para la preparación de un medicamento para el tratamiento de un paciente humano afectado por cáncer mediante terapia de combinaciónInfo
- Publication number
- AR109456A2 AR109456A2 ARP170101288A ARP170101288A AR109456A2 AR 109456 A2 AR109456 A2 AR 109456A2 AR P170101288 A ARP170101288 A AR P170101288A AR P170101288 A ARP170101288 A AR P170101288A AR 109456 A2 AR109456 A2 AR 109456A2
- Authority
- AR
- Argentina
- Prior art keywords
- cancer
- preparation
- treatment
- combination therapy
- human patient
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- 238000002648 combination therapy Methods 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 abstract 1
- 229960003957 dexamethasone Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Uso de ET743 para la preparación de un medicamento para el tratamiento de un paciente humano afectado por cáncer mediante terapia de combinación, involucrando la administración de ET743 y dexametasona.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9911183.3A GB9911183D0 (en) | 1999-05-13 | 1999-05-13 | Treatment of cancers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR109456A2 true AR109456A2 (es) | 2018-12-12 |
Family
ID=10853439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP170101288A AR109456A2 (es) | 1999-05-13 | 2017-05-15 | Uso de et743 para la preparación de un medicamento para el tratamiento de un paciente humano afectado por cáncer mediante terapia de combinación |
Country Status (4)
| Country | Link |
|---|---|
| CN (1) | CN101181272A (es) |
| AR (1) | AR109456A2 (es) |
| ES (1) | ES2363064T3 (es) |
| GB (1) | GB9911183D0 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112574234B (zh) * | 2019-09-27 | 2022-05-24 | 江苏恒瑞医药股份有限公司 | 一种海鞘素衍生物的制备方法 |
-
1999
- 1999-05-13 GB GBGB9911183.3A patent/GB9911183D0/en not_active Ceased
-
2000
- 2000-05-15 CN CNA2007101863681A patent/CN101181272A/zh active Pending
- 2000-05-15 ES ES06014005T patent/ES2363064T3/es not_active Expired - Lifetime
-
2017
- 2017-05-15 AR ARP170101288A patent/AR109456A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| GB9911183D0 (en) | 1999-07-14 |
| CN101181272A (zh) | 2008-05-21 |
| ES2363064T3 (es) | 2011-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE515265T1 (de) | Vitamin d und dessen analoge zur behandlung vom tumoren und anderen hyperproliferativen erkrankungen | |
| CY1112361T1 (el) | Σκευασματα για αντικαρκινικη θεραπεια που περιεχουν εκτεϊνασκιδινη 743 | |
| PT1173178E (pt) | Composicao compreendendo apomorfina e sildenafil e utilizacao da mesma para o tratamento da disfuncao erectil | |
| EP1194173A4 (en) | X-RAY CONTROLLED DRUG RELEASE | |
| ATE309798T1 (de) | Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate | |
| IL195723A (en) | Use of p53 inhibitors for the preparation of medicament | |
| TR200001891T2 (tr) | ASPB28- İnsan ensülini ve kullanımı. | |
| TW200501945A (en) | Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases | |
| BRPI0406858A (pt) | Liberação controlada de agentes altamente solúveis | |
| AR023687A1 (es) | Una composicion para el tratamiento de desordenes de la retina externa y el uso de un antagonista de glutamato para la manufactura de un medicamento parael tratamiento de desordenes de la retina externa | |
| ES2191449T3 (es) | Derivados de ciclopentabenzofurano y su uso. | |
| HRP20090345T1 (en) | Pegylated liposomal doxorubicin in combination with ecteinescidin 743 | |
| MXPA04001912A (es) | Aminobenzofenonas novedosas. | |
| CA2385755A1 (en) | Prevention of colorectal cancer | |
| AR109456A2 (es) | Uso de et743 para la preparación de un medicamento para el tratamiento de un paciente humano afectado por cáncer mediante terapia de combinación | |
| AR027394A1 (es) | Uso de mirtazapina para el tratamiento de trastornos del sueno | |
| AR034142A1 (es) | Una composicion farmaceutica, metodo para fabricar un medicamento en base a dicha composicion y uso de la composicion | |
| AR048318A1 (es) | Formulaciones de matriz orales que comprenden licarbazepina | |
| AU3401093A (en) | Therapeutic agent for threatened abortion | |
| IL156144A0 (en) | Novel therapeutic use of a thienylcyclohexylamine derivative | |
| BR0311141A (pt) | Interação sinergìstica de abacavir e alovudine | |
| MD1780G2 (ro) | Metodă de tratament al pacienţilor cu ciroze hepatice | |
| BR0312283A (pt) | Combinação compreendendo um agente de alquilação e um agente redutor da atividade de vegf | |
| NZ516564A (en) | Cancer therapy | |
| Nicholson | Ask the doctor. In your article on Alzheimer's disease (March, 1999), you mention" high doses of vitamin E" as helpful in slowing the progression of the condition. Specifically, what dose is recommended? |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |